Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: A report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health

Lars Hagmar, Stefano Bonassi, Ulf Strömberg, Zoli Mikoczy, Cecilia Lando, Inger Lise Hansteen, Alicia Huici Montagud, Lisbeth Knudsen, Hannu Norppa, Christina Reuterwall, Håkan Tinnerberg, Anton Brøgger, Alessandra Forni, Benkt Högstedt, Bo Lambert, Felix Mitelman, Ingrid Nordenson, Sisko Salomaa, Staffan Skerfving

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

The cytogenetic endpoints in peripheral blood lymphocytes: chromosomal aberrations (CA), sister chromatid exchange (SCE) and micronuclei (MN) are established biomarkers of exposure for mutagens or carcinogens in the work environment. However, it is not clear whether these biomarkers also may serve as biomarkers for genotoxic effects which will result in an enhanced cancer risk. In order to assess this problem, Nordic and Italian cohorts were established, and preliminary results from these two studies indicated a predictive value of CA frequency for cancer risk, whereas no such associations were observed for SCE or MN. A collaborative study between the Nordic and Italian research groups, will enable a more thorough evaluation of the cancer predictivity of the cytogenetic endpoints. We here report on the establishment of a joint data base comprising 5271 subjects, examined 1965-1988 for at least one cytogenetic biomarker. Totally, 3540 subjects had been examined for CA, 2702 for SCE and 1496 for MN. These cohorts have been followed-up with respect to subsequent cancer mortality or cancer incidence, and the expected values have been calculated from rates derived from the general populations in each country. Stratified cohort analyses will be performed with respect to the levels of the cytogenetic biomarkers. The importance of potential effect modifiers such as gender, age at test, and time since test, will be evaluated using Poisson regression models. The remaining two potential effect modifiers, occupational exposures and smoking, will be assessed in a case-referent study within the study base. Copyright (C) 1998 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)171-178
Number of pages8
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume405
Issue number2
DOIs
Publication statusPublished - Sep 20 1998

Fingerprint

Occupational Health
Cytogenetics
Biomarkers
Sister Chromatid Exchange
Chromosome Aberrations
Health
Neoplasms
Mutagens
Occupational Exposure
Carcinogens
Case-Control Studies
Cohort Studies
Joints
Smoking
Databases
Lymphocytes
Mortality
Incidence
Research
Population

Keywords

  • Cancer incidence
  • Cancer mortality
  • Chromosomal aberration
  • Cohort-based case-referent study
  • Effect modifier
  • Micronucleus
  • Occupational exposure assessment
  • Prospective cohort study
  • Sister chromatid exchange

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Molecular Biology

Cite this

Cancer predictive value of cytogenetic markers used in occupational health surveillance programs : A report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. / Hagmar, Lars; Bonassi, Stefano; Strömberg, Ulf; Mikoczy, Zoli; Lando, Cecilia; Hansteen, Inger Lise; Montagud, Alicia Huici; Knudsen, Lisbeth; Norppa, Hannu; Reuterwall, Christina; Tinnerberg, Håkan; Brøgger, Anton; Forni, Alessandra; Högstedt, Benkt; Lambert, Bo; Mitelman, Felix; Nordenson, Ingrid; Salomaa, Sisko; Skerfving, Staffan.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 405, No. 2, 20.09.1998, p. 171-178.

Research output: Contribution to journalArticle

Hagmar, L, Bonassi, S, Strömberg, U, Mikoczy, Z, Lando, C, Hansteen, IL, Montagud, AH, Knudsen, L, Norppa, H, Reuterwall, C, Tinnerberg, H, Brøgger, A, Forni, A, Högstedt, B, Lambert, B, Mitelman, F, Nordenson, I, Salomaa, S & Skerfving, S 1998, 'Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: A report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health', Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, vol. 405, no. 2, pp. 171-178. https://doi.org/10.1016/S0027-5107(98)00134-1
Hagmar, Lars ; Bonassi, Stefano ; Strömberg, Ulf ; Mikoczy, Zoli ; Lando, Cecilia ; Hansteen, Inger Lise ; Montagud, Alicia Huici ; Knudsen, Lisbeth ; Norppa, Hannu ; Reuterwall, Christina ; Tinnerberg, Håkan ; Brøgger, Anton ; Forni, Alessandra ; Högstedt, Benkt ; Lambert, Bo ; Mitelman, Felix ; Nordenson, Ingrid ; Salomaa, Sisko ; Skerfving, Staffan. / Cancer predictive value of cytogenetic markers used in occupational health surveillance programs : A report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 1998 ; Vol. 405, No. 2. pp. 171-178.
@article{221ee041992e48e69d0a62b86767d0b7,
title = "Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: A report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health",
abstract = "The cytogenetic endpoints in peripheral blood lymphocytes: chromosomal aberrations (CA), sister chromatid exchange (SCE) and micronuclei (MN) are established biomarkers of exposure for mutagens or carcinogens in the work environment. However, it is not clear whether these biomarkers also may serve as biomarkers for genotoxic effects which will result in an enhanced cancer risk. In order to assess this problem, Nordic and Italian cohorts were established, and preliminary results from these two studies indicated a predictive value of CA frequency for cancer risk, whereas no such associations were observed for SCE or MN. A collaborative study between the Nordic and Italian research groups, will enable a more thorough evaluation of the cancer predictivity of the cytogenetic endpoints. We here report on the establishment of a joint data base comprising 5271 subjects, examined 1965-1988 for at least one cytogenetic biomarker. Totally, 3540 subjects had been examined for CA, 2702 for SCE and 1496 for MN. These cohorts have been followed-up with respect to subsequent cancer mortality or cancer incidence, and the expected values have been calculated from rates derived from the general populations in each country. Stratified cohort analyses will be performed with respect to the levels of the cytogenetic biomarkers. The importance of potential effect modifiers such as gender, age at test, and time since test, will be evaluated using Poisson regression models. The remaining two potential effect modifiers, occupational exposures and smoking, will be assessed in a case-referent study within the study base. Copyright (C) 1998 Elsevier Science B.V.",
keywords = "Cancer incidence, Cancer mortality, Chromosomal aberration, Cohort-based case-referent study, Effect modifier, Micronucleus, Occupational exposure assessment, Prospective cohort study, Sister chromatid exchange",
author = "Lars Hagmar and Stefano Bonassi and Ulf Str{\"o}mberg and Zoli Mikoczy and Cecilia Lando and Hansteen, {Inger Lise} and Montagud, {Alicia Huici} and Lisbeth Knudsen and Hannu Norppa and Christina Reuterwall and H{\aa}kan Tinnerberg and Anton Br{\o}gger and Alessandra Forni and Benkt H{\"o}gstedt and Bo Lambert and Felix Mitelman and Ingrid Nordenson and Sisko Salomaa and Staffan Skerfving",
year = "1998",
month = "9",
day = "20",
doi = "10.1016/S0027-5107(98)00134-1",
language = "English",
volume = "405",
pages = "171--178",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Cancer predictive value of cytogenetic markers used in occupational health surveillance programs

T2 - A report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health

AU - Hagmar, Lars

AU - Bonassi, Stefano

AU - Strömberg, Ulf

AU - Mikoczy, Zoli

AU - Lando, Cecilia

AU - Hansteen, Inger Lise

AU - Montagud, Alicia Huici

AU - Knudsen, Lisbeth

AU - Norppa, Hannu

AU - Reuterwall, Christina

AU - Tinnerberg, Håkan

AU - Brøgger, Anton

AU - Forni, Alessandra

AU - Högstedt, Benkt

AU - Lambert, Bo

AU - Mitelman, Felix

AU - Nordenson, Ingrid

AU - Salomaa, Sisko

AU - Skerfving, Staffan

PY - 1998/9/20

Y1 - 1998/9/20

N2 - The cytogenetic endpoints in peripheral blood lymphocytes: chromosomal aberrations (CA), sister chromatid exchange (SCE) and micronuclei (MN) are established biomarkers of exposure for mutagens or carcinogens in the work environment. However, it is not clear whether these biomarkers also may serve as biomarkers for genotoxic effects which will result in an enhanced cancer risk. In order to assess this problem, Nordic and Italian cohorts were established, and preliminary results from these two studies indicated a predictive value of CA frequency for cancer risk, whereas no such associations were observed for SCE or MN. A collaborative study between the Nordic and Italian research groups, will enable a more thorough evaluation of the cancer predictivity of the cytogenetic endpoints. We here report on the establishment of a joint data base comprising 5271 subjects, examined 1965-1988 for at least one cytogenetic biomarker. Totally, 3540 subjects had been examined for CA, 2702 for SCE and 1496 for MN. These cohorts have been followed-up with respect to subsequent cancer mortality or cancer incidence, and the expected values have been calculated from rates derived from the general populations in each country. Stratified cohort analyses will be performed with respect to the levels of the cytogenetic biomarkers. The importance of potential effect modifiers such as gender, age at test, and time since test, will be evaluated using Poisson regression models. The remaining two potential effect modifiers, occupational exposures and smoking, will be assessed in a case-referent study within the study base. Copyright (C) 1998 Elsevier Science B.V.

AB - The cytogenetic endpoints in peripheral blood lymphocytes: chromosomal aberrations (CA), sister chromatid exchange (SCE) and micronuclei (MN) are established biomarkers of exposure for mutagens or carcinogens in the work environment. However, it is not clear whether these biomarkers also may serve as biomarkers for genotoxic effects which will result in an enhanced cancer risk. In order to assess this problem, Nordic and Italian cohorts were established, and preliminary results from these two studies indicated a predictive value of CA frequency for cancer risk, whereas no such associations were observed for SCE or MN. A collaborative study between the Nordic and Italian research groups, will enable a more thorough evaluation of the cancer predictivity of the cytogenetic endpoints. We here report on the establishment of a joint data base comprising 5271 subjects, examined 1965-1988 for at least one cytogenetic biomarker. Totally, 3540 subjects had been examined for CA, 2702 for SCE and 1496 for MN. These cohorts have been followed-up with respect to subsequent cancer mortality or cancer incidence, and the expected values have been calculated from rates derived from the general populations in each country. Stratified cohort analyses will be performed with respect to the levels of the cytogenetic biomarkers. The importance of potential effect modifiers such as gender, age at test, and time since test, will be evaluated using Poisson regression models. The remaining two potential effect modifiers, occupational exposures and smoking, will be assessed in a case-referent study within the study base. Copyright (C) 1998 Elsevier Science B.V.

KW - Cancer incidence

KW - Cancer mortality

KW - Chromosomal aberration

KW - Cohort-based case-referent study

KW - Effect modifier

KW - Micronucleus

KW - Occupational exposure assessment

KW - Prospective cohort study

KW - Sister chromatid exchange

UR - http://www.scopus.com/inward/record.url?scp=0012613244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0012613244&partnerID=8YFLogxK

U2 - 10.1016/S0027-5107(98)00134-1

DO - 10.1016/S0027-5107(98)00134-1

M3 - Article

C2 - 9748557

AN - SCOPUS:0012613244

VL - 405

SP - 171

EP - 178

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 2

ER -